Delivery Order SPE2DB22D2214-SPE2DB24FS2ZE
- Not listed
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Tresiba FlexTouch insulin pens. The contract has a ceiling value of $2,416.33 and a completion date of June 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide this insulin product to fulfill the government's medical supply requirements. The contract is not set aside for any small business category. Amerisourcebergen holds a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba Flextouch insulin pens. The $7,699.35 firm fixed price contract has an ultimate completion date of August 21, 2024. This order is part of a broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order has a ceiling value of $4,103.94 and is for the delivery of Tresiba FlexTouch insulin pens. The contract is a firm fixed-price delivery order with an ultimate completion date of September 20, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 100 unit/mL 3mL insulin cartridges. The contract has a ceiling value of $1,334.52 and runs through December 29, 2022. This appears to be a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for $2,001.55 to supply Tresiba Flextouch 200 unit/mL 3mL insulin pens. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Tresiba Flextouch 200 unit/mL 3mL insulin delivery pens. The single-award Delivery Order, valued at $15,711.19, has a firm fixed price and was not designated with a set-aside requirement. The contract has an ultimate completion date of April 26, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin medication. The contract has a ceiling value of $1,245.69 and a completion date of July 1, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The award has a ceiling value of $24,484.26 and a period of performance through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba Flextouch insulin pens. The order, valued at $8,181.93, has a firm fixed-price contract type and an ultimate completion date of August 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA...
- The Defense Logistics Agency awarded a delivery order valued at approximately $74,717 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes a firm fixed price structure and carries no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS2ZEDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract has a ceiling value of $21,963.79 and a completion date of December 19, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.0k | 12/18/23 |